Microbes in multiple roles
The program moves from microbiota transfer and bacterial antigen expression to AhR–IL-22–STAT3 repair, surfactin-mediated fusion inhibition, and extracellular-vesicle RNA delivery.
Using beneficial and engineered microbes as models, carriers, repair signals, and antiviral systems.
The program moves from microbiota transfer and bacterial antigen expression to AhR–IL-22–STAT3 repair, surfactin-mediated fusion inhibition, and extracellular-vesicle RNA delivery.
Human-flora-associated piglets, mice, intestinal organoids, porcine epithelial systems, H9N2 models, and engineered Lactobacillus and Bacillus strains.
Controlled colonization, bacterial engineering, immune assays, organoid coculture, metabolite and signaling tests, membrane biophysics, animal challenge, and RNAi measurements.
The evidence explores low-intervention ways to deliver antigens or RNA, repair barriers, or interfere directly with viral entry.
Independent editorial synthesis · reviewed 7 September 2026
ORCID 0000-0002-2349-0028 · NJAU College of Veterinary Medicine
Six papers selected for conceptual importance and temporal coverage. They are examples, not a substitute for the complete reconciled bibliography.
Human donor microbiota produced a donor-like community in germ-free piglets, establishing a model rather than a probiotic treatment.
Independently verified record · role not statedTwo recombinant Lactobacillus strains induced antigen-specific responses after oral delivery in mice; the abstract does not supply challenge evidence.
Official bibliography role: Correspondence AuthorA Lactobacillus metabolite activated an AhR–IL-22–STAT3 pathway that accelerated intestinal stem-cell regeneration in mouse and organoid models.
Official bibliography role: Participating authorsSurfactin inserted into viral-envelope lipids and reduced fusion; oral treatment protected piglets in the reported PEDV challenge, not every enveloped-virus setting.
Official bibliography role: Correspondence AuthorA nasal-colonizing Bacillus strain and its metabolites altered viral-envelope properties; the surveillance association alone does not establish causality.
Official bibliography role: Correspondence AuthorEngineered Bacillus exported antiviral dsRNA in extracellular vesicles and reduced H9N2 burden in the reported preclinical system; field performance remains untested.
Independently verified record · role not statedThese overlapping themes are an editorial synthesis of the publication record. They do not claim sole scientific ownership, clinical validation, regulatory approval, or independent replication. Titles and bibliographic facts come from the reconciled record; explanatory summaries are constrained to the cited evidence.